Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma

[1]  Yanli Li,et al.  Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma , 2022, Cells.

[2]  W. Zou,et al.  CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. , 2022, Cancer cell.

[3]  B. Melichar,et al.  Lipidomic profiling of human serum enables detection of pancreatic cancer , 2022, Nature Communications.

[4]  W. Mao,et al.  Lipid Profiling in Malignant Mesothelioma Reveals Promising Signatures for Diagnosis and Prognosis: A Plasma-Based LC-MS Lipidomics Study. , 2021, Clinica chimica acta; international journal of clinical chemistry.

[5]  Yixuan Hou,et al.  A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties , 2021, Journal of Hematology & Oncology.

[6]  G. van Echten-Deckert,et al.  Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindrance , 2021, Molecular oncology.

[7]  O. Feron,et al.  Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. , 2021, Cell metabolism.

[8]  W. Xia,et al.  An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features. , 2021, Oral Oncology.

[9]  A. Shevchenko,et al.  The colorectal cancer lipidome - identification of a robust tumor-specific lipid species signature. , 2021, Gastroenterology.

[10]  S. Reis,et al.  Analysis of the Plasma Metabolome after Trauma, Novel Circulating Sphingolipid Signatures, and In-Hospital Outcomes. , 2021, Journal of the American College of Surgeons.

[11]  S. Zhong,et al.  Insights into the prognosis of lipidomic dysregulation for death risk in patients with coronary artery disease , 2020, Clinical and translational medicine.

[12]  M. Loda,et al.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. , 2020, Advanced drug delivery reviews.

[13]  Gek Huey Chua,et al.  Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis , 2020, Cell Metabolism.

[14]  W. Buchberger,et al.  Determination of a Tumor-Promoting Microenvironment in Recurrent Medulloblastoma: A Multi-Omics Study of Cerebrospinal Fluid , 2020, Cancers.

[15]  T. Wakai,et al.  Clinical application of ceramide in cancer treatment , 2019, Breast Cancer.

[16]  M. Kalady,et al.  Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. , 2019, Cell metabolism.

[17]  L. Horvath,et al.  Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer , 2019, Molecular Cancer Research.

[18]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[19]  Uri Shaham,et al.  DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network , 2016, BMC Medical Research Methodology.

[20]  Zhaoli Chen,et al.  Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic Profiling , 2018, Clinical Cancer Research.

[21]  S. Melo,et al.  The Biology of Cancer Exosomes: Insights and New Perspectives. , 2017, Cancer research.

[22]  E. P. von Strandmann,et al.  Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.

[23]  M. Stockler,et al.  A distinct plasma lipid signature associated with poor prognosis in castration‐resistant prostate cancer , 2017, International Journal of Cancer.

[24]  Y. Pinto,et al.  Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients. , 2017, JACC. Heart failure.

[25]  G. Freeman,et al.  Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy. , 2017, Cancer cell.

[26]  Pengyuan Yang,et al.  Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism , 2017, Hepatology.

[27]  P. Cirri,et al.  Metabolic exchanges within tumor microenvironment. , 2016, Cancer letters.

[28]  W. Xue,et al.  Global trends in incidence and mortality of nasopharyngeal carcinoma. , 2016, Cancer letters.

[29]  Wei Yang,et al.  Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism , 2016, Nature.

[30]  H. Dienemann,et al.  Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles , 2015, International journal of cancer.

[31]  G. Xie,et al.  Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. , 2014, Journal of proteome research.

[32]  Carsten Denkert,et al.  Monounsaturated fatty acids in serum triacylglycerols are associated with response to neoadjuvant chemotherapy in breast cancer patients , 2014, International journal of cancer.

[33]  E. Lengyel,et al.  Adipose tissue and adipocytes support tumorigenesis and metastasis. , 2013, Biochimica et biophysica acta.

[34]  Thomas A Gerds,et al.  Estimating a time‐dependent concordance index for survival prediction models with covariate dependent censoring , 2013, Statistics in medicine.

[35]  L. Qiu,et al.  Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[36]  W. Jia,et al.  Metabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression. , 2012, Journal of proteome research.

[37]  P. Domingues,et al.  Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cells , 2012, Breast Cancer Research and Treatment.

[38]  G. Nixon.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets , 2009, British journal of pharmacology.

[39]  Ying Sun,et al.  Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. , 2009, International journal of radiation oncology, biology, physics.

[40]  K. Hornik,et al.  Unbiased Recursive Partitioning: A Conditional Inference Framework , 2006 .

[41]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[42]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[43]  E. Bieberich,et al.  Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy: CHAPTER FIVE , 2018, Advances in cancer research.

[44]  Rui Sun,et al.  Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma. , 2016, Journal of the National Cancer Institute.

[45]  Achim Zeileis,et al.  Partykit: a modular toolkit for recursive partytioning in R , 2015, J. Mach. Learn. Res..

[46]  P. Cirri,et al.  Cancer associated fibroblasts: the dark side of the coin. , 2011, American journal of cancer research.

[47]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..